We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » China to Pharma: Stop Foot-Dragging on New Vaccine GMP Certificates
China to Pharma: Stop Foot-Dragging on New Vaccine GMP Certificates
In the wake of a rash of infant deaths related to GMP-certified hepatitis B vaccines, China is renewing its push to have makers of vaccines, blood products and sterile injectables obtain a revised good manufacturing practice certificate.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor